# Amgen has an analyst consensus of Moderate Buy, with a price target consensus of $363.33, a 10.16% upside from current levels.

*biotech · news · 2026-05-02 · Markets Insider*

## Key points

- Raymond James assigned a Hold rating to Amgen in a report released yesterday.
- Bernstein maintained a Hold rating on Amgen with a $335.00 price target in their latest report.
- Amgen's analyst consensus price target is $363.33, indicating a 10.16% potential upside.
- Amgen reported quarterly revenue of $8.62 billion, up from $8.15 billion the previous year.

**Companies:** Amgen

[Read the full story on Markets Insider](https://markets.businessinsider.com/news/stocks/raymond-james-issues-a-hold-rating-on-amgen-amgn-1036097588)

---

Canonical: https://newsio.io/n/4c1671b7-23d8-49bb-be47-3ebe48861775/amgen-has-an-analyst-consensus-of-moderate-buy-with-a-price-target-consensus-of
Summarized by Newsio from Markets Insider. https://newsio.io/how-it-works